Artikler med mandater om offentlig tilgang - John E. HarrisLes mer
Ikke tilgjengelige noe sted: 4
New discoveries in the pathogenesis and classification of vitiligo
M Rodrigues, K Ezzedine, I Hamzavi, AG Pandya, JE Harris, ...
Journal of the American Academy of Dermatology 77 (1), 1-13, 2017
Mandater: US National Institutes of Health
Current and emerging treatments for vitiligo
M Rodrigues, K Ezzedine, I Hamzavi, AG Pandya, JE Harris, ...
Journal of the American Academy of Dermatology 77 (1), 17-29, 2017
Mandater: US National Institutes of Health
Vitiligo is not a cosmetic disease
K Ezzedine, V Sheth, M Rodrigues, V Eleftheriadou, JE Harris, ...
Journal of the American Academy of Dermatology 73 (5), 883-885, 2015
Mandater: US National Institutes of Health
Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus
V Eleftheriadou, K Thomas, N van Geel, I Hamzavi, H Lim, T Suzuki, ...
Pigment cell & melanoma research 28 (3), 363-369, 2015
Mandater: National Institute for Health Research, UK
Tilgjengelige et eller annet sted: 70
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 399 (10325), 665-676, 2022
Mandater: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
M Rashighi, P Agarwal, JM Richmond, TH Harris, K Dresser, MW Su, ...
Science translational medicine 6 (223), 223ra23-223ra23, 2014
Mandater: US National Institutes of Health
A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin
JE Harris, TH Harris, W Weninger, EJ Wherry, CA Hunter, LA Turka
Journal of Investigative Dermatology 132 (7), 1869-1876, 2012
Mandater: US National Institutes of Health
Vitiligo pathogenesis and emerging treatments
M Rashighi, JE Harris
Dermatologic clinics 35 (2), 257-265, 2017
Mandater: US National Institutes of Health
Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
LY Liu, JP Strassner, MA Refat, JE Harris, BA King
Journal of the American Academy of Dermatology 77 (4), 675-682. e1, 2017
Mandater: US National Institutes of Health
Innate immune mechanisms in vitiligo: danger from within
JM Richmond, ML Frisoli, JE Harris
Current opinion in immunology 25 (6), 676-682, 2013
Mandater: US National Institutes of Health
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
JM Richmond, JP Strassner, L Zapata Jr, M Garg, RL Riding, MA Refat, ...
Science translational medicine 10 (450), eaam7710, 2018
Mandater: US National Institutes of Health
Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
JE Harris, M Rashighi, N Nguyen, A Jabbari, G Ulerio, R Clynes, ...
Journal of the American Academy of Dermatology 74 (2), 370-371, 2016
Mandater: US National Institutes of Health
Immunology and skin in health and disease
JM Richmond, JE Harris
Cold Spring Harbor perspectives in medicine 4 (12), a015339, 2014
Mandater: US National Institutes of Health
Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease
JM Richmond, DS Bangari, KI Essien, SD Currimbhoy, JR Groom, ...
Journal of Investigative Dermatology 137 (2), 350-358, 2017
Mandater: US National Institutes of Health
A network of high-mobility group box transcription factors programs innate interleukin-17 production
N Malhotra, K Narayan, OH Cho, KE Sylvia, C Yin, H Melichar, ...
Immunity 38 (4), 681-693, 2013
Mandater: US National Institutes of Health
CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses
SZ Chong, M Evrard, S Devi, J Chen, JY Lim, P See, Y Zhang, JM Adrover, ...
Journal of Experimental Medicine 213 (11), 2293-2314, 2016
Mandater: US National Institutes of Health, German Research Foundation, A*Star, Singapore
Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo
JM Richmond, JP Strassner, M Rashighi, P Agarwal, M Garg, KI Essien, ...
Journal of Investigative Dermatology 139 (4), 769-778, 2019
Mandater: US National Institutes of Health
The role of memory CD8+ T cells in vitiligo
RL Riding, JE Harris
The Journal of Immunology 203 (1), 11-19, 2019
Mandater: US National Institutes of Health
Chemical-induced vitiligo
JE Harris
Dermatologic clinics 35 (2), 151-161, 2017
Mandater: US National Institutes of Health
Cellular stress and innate inflammation in organ‐specific autoimmunity: lessons learned from vitiligo
JE Harris
Immunological Reviews 269 (1), 11-25, 2016
Mandater: US National Institutes of Health
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram